Warning ArQule, Inc. (ARQL) pessimists! Paolo Pucci just Acquired 15,000 shares.; QTS Realty Trust Has 1.49 Sentiment

May 18, 2018 - By Pete Kolinski

ArQule, Inc. (NASDAQ:ARQL) Logo

Sentiment for QTS Realty Trust Inc (QTS)

QTS Realty Trust Inc (QTS) investors sentiment decreased to 1.49 in 2017 Q4. It’s down -0.41, from 1.9 in 2017Q3. The ratio is negative, as 104 hedge funds increased and opened new positions, while 70 reduced and sold stock positions in QTS Realty Trust Inc. The hedge funds in our database now have: 52.78 million shares, up from 49.80 million shares in 2017Q3. Also, the number of hedge funds holding QTS Realty Trust Inc in top ten positions was flat from 4 to 4 for the same number . Sold All: 24 Reduced: 46 Increased: 79 New Position: 25.

More recent ArQule, Inc. (NASDAQ:ARQL) news were published by: Streetinsider.com which released: “Pre-Open Movers 05/18: (QTNT) (AFSI) (CERN) Higher; (AGRX) (ARQL) (CPB) Lower (more..)” on May 18, 2018. Also Streetinsider.com published the news titled: “After-Hours Stock Movers 05/17: (QTNT) (VJET) (AFSI) Higher; (ARQL) (JWN) (AMAT) Lower (more..)” on May 17, 2018. Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: AstraZeneca’s Q1, Novartis-Amgen Migraine Drug Approved” with publication date: May 18, 2018 was also an interesting one.

Analysts await ArQule, Inc. (NASDAQ:ARQL) to report earnings on August, 3. They expect $-0.05 EPS, up 50.00% or $0.05 from last year’s $-0.1 per share. After $-0.07 actual EPS reported by ArQule, Inc. for the previous quarter, Wall Street now forecasts -28.57% EPS growth.

Among 6 analysts covering ArQule (NASDAQ:ARQL), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ArQule has $5 highest and $3.0 lowest target. $4.30’s average target is 28.74% above currents $3.34 stock price. ArQule had 7 analyst reports since December 9, 2015 according to SRatingsIntel. The stock has “Mkt Perform” rating by Leerink Swann on Wednesday, December 9. The company was maintained on Monday, February 12 by B. Riley & Co. The firm has “Buy” rating by FBR Capital given on Friday, February 2. The stock has “Outperform” rating by RBC Capital Markets on Monday, December 21. Leerink Swann upgraded it to “Buy” rating and $500 target in Thursday, April 5 report. As per Thursday, December 14, the company rating was upgraded by Needham.

The stock decreased 7.99% or $0.29 during the last trading session, reaching $3.34. About 1.07M shares traded or 7.68% up from the average. ArQule, Inc. (NASDAQ:ARQL) has risen 180.00% since May 18, 2017 and is uptrending. It has outperformed by 168.45% the S&P500.

Arqule Inc Chief Executive Officer and an insider Paolo Pucci lately paid for 15,000 company shares having a value of $50,849 at an avg. stock price per share of $3.4. He also purchased 1,300 shares with a total value $3,427 USD in the last 30 days. The date of trade was 18/05/2018, and it was made public in a SEC-filed filing, which you can read here. Paolo Pucci currently possess 420,494 shares or 0.48% of Arqule Inc’s market cap.

ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. The company has market cap of $291.00 million. The Company’s lead product candidate is tivantinib , a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer. It currently has negative earnings. The company's clinical-stage products include ARQ 087, a multi-kinase inhibitor of the fibroblast growth factor receptor (FGFR) family Phase II clinical trial for patients with intrahepatic cholangiocarcinoma and in Phase Ib for multiple oncology indications; ARQ 092, an inhibitor of the AKT serine/threonine kinase in Phase I clinical trials for multiple oncology indications; ARQ 751, a next-generation inhibitor of AKT in Phase I clinical trial for solid tumors; and ARQ 761, an intravenously administered analogue of Beta-lapachone, which is Phase 1b clinical trial used as a promoter of NQo1-mediated programmed cancer cell death.

QTS Realty Trust, Inc. focuses on the ownership, development, and operation of carrier-neutral data centers in the United States. The company has market cap of $1.95 billion.

Ratings analysis reveals 100% of QTS Realty Trust’s analysts are positive. Out of 3 Wall Street analysts rating QTS Realty Trust, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. QTS was included in 3 notes of analysts from October 7, 2016. The rating was upgraded by Stifel Nicolaus to “Buy” on Tuesday, January 31. The stock of QTS Realty Trust, Inc. (NYSE:QTS) earned “Buy” rating by Guggenheim on Friday, December 2. Raymond James initiated QTS Realty Trust, Inc. (NYSE:QTS) on Friday, October 7 with “Outperform” rating.

Land & Buildings Investment Management Llc holds 5.36% of its portfolio in QTS Realty Trust, Inc. for 478,860 shares. American Trust Investment Advisors Llc owns 71,580 shares or 3.04% of their US portfolio. Moreover, Aristotle Capital Boston Llc has 1.88% invested in the company for 475,401 shares. The Massachusetts-based Eagle Boston Investment Management Inc has invested 1.71% in the stock. Emerald Advisers Inc Pa, a Pennsylvania-based fund reported 593,860 shares.

Analysts await QTS Realty Trust, Inc. (NYSE:QTS) to report earnings on July, 24. They expect $0.65 EPS, up 3.17% or $0.02 from last year’s $0.63 per share. QTS’s profit will be $37.58M for 12.98 P/E if the $0.65 EPS becomes a reality. After $0.68 actual EPS reported by QTS Realty Trust, Inc. for the previous quarter, Wall Street now forecasts -4.41% negative EPS growth.

The stock decreased 1.85% or $0.635 during the last trading session, reaching $33.745. About 163,514 shares traded. QTS Realty Trust, Inc. (QTS) has declined 26.55% since May 18, 2017 and is downtrending. It has underperformed by 38.10% the S&P500.

More notable recent QTS Realty Trust, Inc. (NYSE:QTS) news were published by: Prnewswire.com which released: “QTS Welcomes Passage of Georgia Tax Incentive Legislation for Data Centers” on May 17, 2018, also Prnewswire.com with their article: “All QTS Directors Reelected at Annual Meeting” published on May 03, 2018, Prnewswire.com published: “QTS Realty Trust, Inc. to Present at the JP Morgan Global Technology, Media and Communications Conference” on May 09, 2018. More interesting news about QTS Realty Trust, Inc. (NYSE:QTS) were released by: Seekingalpha.com and their article: “QTS Realty Trust’s (QTS) CEO Chad Williams on Q1 2018 Results – Earnings Call Transcript” published on April 26, 2018 as well as Businesswire.com‘s news article titled: “Land & Buildings Comments on Results of QTS Annual Meeting” with publication date: May 07, 2018.

QTS Realty Trust, Inc. (NYSE:QTS) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts